EndoChoice has released its unaudited, preliminary financial results for the fourth quarter and full year of 2015.
The scope maker expects to report $18.6 million in total revenue for the fourth quarter, up from $18.3 million in the fourth quarter of 2014. Revenue for the full year is predicted to be $72.3 million, up 18 percent from $61.4 million in 2014.
The company's fourth quarter revenue consisted of:
• Imaging: $5.2 million
• Single-use products: $9.5 million
• Pathology: $3.9 million
EndoChoice shipped 25 of its Fuse Endoscopy systems during the fourth quarter of 2015, and a total of 99 were shipped for the full year. The company will report its full fourth quarter and full year financial results March 3.